comparemela.com

Latest Breaking News On - Subject experts committee - Page 1 : comparemela.com

Aurobindo Pharma arm gets CDSCO panel nod to market biosimilar of cancer drug

Aurobindo Pharma arm gets CDSCO panel nod to market biosimilar of cancer drug
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Aurobindo pharmaSatakarni makkapatiCurateq biologicsSubject experts committeeCentral drugs standard control organizationPeptides satakarni makkapati

CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E’s CORBEVAX as a heterologous booster for adults above 18 yrs old

Andhra pradeshMahima datlaExperts committeeBe limitedNational technical advisory group on immunisationNational technical advisory groupDrug controller generalSubject experts committeeManaging directorLatest covid newsOrbevax booster shotVaccination india

WHO approves Biological E Limited as additional manufacturing site for Johnson & Johnson COVID-19 vaccine

US Embassy in India congratulated Biological E

Andhra pradeshBaylor college of medicineUnited statesJanssen johnsonMahima datlaUs embassyExperts committeeQuad vaccineDrug controller generalSubject experts committeeManaging directorTexas childrenBaylor collegeCovid 19Ews india

WHO approves Biological E Limited as additional manufacturing site for Johnson Johnson COVID-19 vaccine

US Embassy in India congratulated Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company for getting approval from WHO as an additional ma

Andhra pradeshBaylor college of medicineUnited statesNew delhiJanssen johnsonMahima datlaJanssen johnsonjohnsonUs embassyExperts committeeQuad vaccineDrug controller generalSubject experts committeeManaging directorTexas childrenBaylor collegeHealth news

CORBEVAX bags DCGI nod as heterologous COVID-19 booster dose

BE has conducted a multicentre Phase III placebo-controlled heterologous booster clinical trial in 416 subjects from 18 to 80 years

Experts committeeDrug controller generalSubject experts committeeCovid 19

vimarsana © 2020. All Rights Reserved.